Aktiesnakken — November 2009
-
mellem Bristol Myers og Alder....
-
Alder laver åbenbart lidt arbejde for Genmab også... nævnes det.
-
-
Bunden er nået når aka holder sin mund omkring fremtidig kursudvikling i Genmab...... eller evt. siger at aktien vil falde mere....
-
der kommer ihvertfald et punkt hvor aka holder kæft, vi er ikke langt fra det
-
det er godt nok trææææls
-
hvad fanden, er du fra jylland aka?
-
det var mere det udtryk "Træææls" - det er der ingen i min kbhske familie der kender
-
jeg kaldte bunden i 116
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind